These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 330945)

  • 1. Blood DDS levels and acetylation rates of sulphadimidine in leprosy patients.
    Balakrishnan S; Ramu G
    Lepr India; 1977 Jan; 49(1):59-64. PubMed ID: 330945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of acetylator phenotype of the leprosy patient on the emergence of dapsone resistant leprosy.
    Raj PP; Aschhoff M; Lilly L; Balakrishnan S
    Indian J Lepr; 1988 Jul; 60(3):400-6. PubMed ID: 3058828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence of DDS resistance in lepromatous patients in Costa Rica: their metabolic disposition of DDS.
    Peters JH; Shepard CC; Gordon GR; Rojas AV; Elizondo DS
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):143-51. PubMed ID: 776849
    [No Abstract]   [Full Text] [Related]  

  • 4. The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment.
    Shepard CC; Levy L; Fasal P
    Am J Trop Med Hyg; 1969 Mar; 18(2):258-63. PubMed ID: 4888029
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug sensitivity of M. leprae isolated from leprosy patients administered DDS for long period of time.
    Murohashi T; Yoshida K
    Acta Leprol; 1978; (73):13-28. PubMed ID: 108909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Resistance of Mycobacterium leprae to dapsone and rifampicin: apropos of a survey carried out in the Cape Verde region (Senegal)].
    Grosset J; Guelpa-Lauras CC; Millan J; Bodian M; Perani E
    Med Trop (Mars); 1987; 47(2):171-5. PubMed ID: 3306248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acedapsone treatment of leprosy patients: response versus drug disposition.
    Peters JH; Murray JF; Gordon GR; Levy L; Russell DA; Scott GC; Vincin DR; Shepard CC
    Am J Trop Med Hyg; 1977 Jan; 26(1):127-36. PubMed ID: 842774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dapsone resistance in Mycobacterium leprae.
    Gillis TP; Williams DL
    Lepr Rev; 2000 Dec; 71 Suppl():S91-5. PubMed ID: 11201896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [2 cases of paucibacillary leprosy resistant to dapsone].
    Janssens L
    Acta Leprol; 1982; (86-87):181-3. PubMed ID: 6815986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DDS resistance in Ethiopia - a progress report.
    Pearson JM; Ross WF; Rees RJ
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):140-2. PubMed ID: 776848
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug resistance of Mycobacterium leprae, particularly to DDS.
    Rees RJ
    Int J Lepr Other Mycobact Dis; 1967; 35(4):625-38. PubMed ID: 4173566
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sulfone-resistance of Mycobacterium leprae--monotherapy with diaminodiphenylsulfone--the value of triple-drug combinations].
    Floch HA
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):122-5. PubMed ID: 3519797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylation of dapsone by human whole blood.
    Irshaid YM; al-Hadidi HF; Abuirjeie MA; Rawashdeh NM; Gharaibeh NS
    Int J Clin Pharmacol Ther Toxicol; 1993 Jan; 31(1):18-22. PubMed ID: 8444513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal inhibitory concentration of dapsone for Mycobacterium leprae in rats.
    Peters JH; Gordon GR; Murray JF; Fieldsteel AH; Levy L
    Antimicrob Agents Chemother; 1975 Nov; 8(5):551-7. PubMed ID: 1108776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Dapsone in chemotherapy of leprosy--a comparison of responses to therapy in two cohorts in 1960s and 1970s.
    Reddy BN; Neelan PN
    Indian J Lepr; 1984; 56(4):912-8. PubMed ID: 6398345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled long-term therapy of leprosy with B663 (lamprene, clofazimine) compared with DDS.
    Tolentino JG; Rodriquez JN; Abalos RM
    Int J Lepr Other Mycobact Dis; 1974; 42(4):416-418. PubMed ID: 4617720
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary dapsone-resistant leprosy in San Francisco.
    Gelber RH
    Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):471-4. PubMed ID: 6399067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphic acetylation of the antibacterials, sulfamethazine and dapsone, in South Indian subjects.
    Peters JH; Gordon GR; Karat AB
    Am J Trop Med Hyg; 1975 Jul; 24(4):641-8. PubMed ID: 1155699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood dapsone levels in leprosy patients treated with acedapsone.
    George J; Balakrishnan S
    Indian J Lepr; 1986; 58(3):401-6. PubMed ID: 3794408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on sulfone resistance in leprosy. 3. A case of "partial" resistance.
    Pearson JM; Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1968; 36(2):171-8. PubMed ID: 4877115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.